Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Royal Caribbean Cruises sell BiotechBee

Start price
€47.73
21.09.22 / 70%
Target price
€39.00
31.12.24
Performance (%)
-2.79%
End price
€46.40
02.01.23
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction for Royal Caribbean Cruises by BiotechBee was down slightly. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Royal Caribbean Cruises 3.987% 3.987% 130.412%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by BiotechBee for this prediction

In the thread Royal Caribbean Cruises diskutieren
Prediction Sell
Perf. (%) -2.79%
Target price 39.000
Change
Ends at 31.12.24

Sell mit Kursziel 39,0

In the thread Trading Royal Caribbean Cruises
Prediction Sell
Perf. (%) -2.79%
Target price 39.000
Change
Ends at 31.12.24

Sell beendet